Sacramento, CA, United States of America

Jason Jevious Parks

This inventor holds 11 USPTO granted patents and 10 published patent applications, plus 1 CIPO patent and 7 EPO patents. Top assignees: Exelixis, Inc., Symphony Evolution, Inc.. Active years: 2009-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jason Jevious Parks. Retrieved from https://idiyas.com/inventor/jason-jevious-parks

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 10)

% Patents Active = 36.4

CIPO Patents = 1

EPO Patents = 7 (Patent Applications = 8)

Average Co-Inventor Count = 14.8

ph-index = 7

Forward Citations = 355(Granted Patents)

Location History:

Sacramento, CA (US) (2009 - 2015)
Elk Grove, CA (US) (2021)

Company Filing History:

Symphony Evolution, Inc.

patents

Years Active: 2009-2021

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11124482 - C-met modulators and methods of use (2021-09-21),

2. 9174947 - c-Met modulators and methods of use (2015-11-03),

3. 8497284 - C-met modulators and method of use (2013-07-30),

4. 8476298 - c-Met modulators and method of use (2013-07-02),

5. 8178532 - c-Met modulators and method of use (2012-05-15),

6. 8076338 - Kinase modulators and methods of use (2011-12-13),

7. 8067436 - c-Met modulators and methods of use (2011-11-29),

8. 8013156 - Tie-2 modulators and methods of use (2011-09-06),

9. 7977345 - c-MET modulators and method of use (2011-07-12),

10. 7626031 - Substituted 3-(diarylmethylene)indolin-2-ones and methods of their use (2009-12-01),

11. 7579473 - c-Met modulators and methods of use (2009-08-25),

Title: Jason Jevious Parks: Innovator in Protein Kinase Modulation

Introduction

Jason Jevious Parks is a notable inventor based in Sacramento, CA. He holds a total of 11 patents, showcasing his significant contributions to the field of biotechnology. His work primarily focuses on the modulation of protein kinase enzymatic activity, which plays a crucial role in various cellular processes.

Latest Patents

Among his latest patents is a groundbreaking invention related to C-met modulators and methods of use. This invention provides compounds designed to modulate protein kinase enzymatic activity, influencing cellular activities such as proliferation, differentiation, programmed cell death, migration, and chemoinvasion. Specifically, the invention introduces quinazolines and quinolines that inhibit, regulate, and/or modulate kinase receptors, particularly c-Met, KDR, c-Kit, flt-3, and flt-4. These compounds are essential for treating kinase-dependent diseases and conditions. Additionally, the invention outlines methods for creating these compounds and the compositions that contain them.

Career Highlights

Jason has worked with prominent companies in the biotechnology sector, including Exelixis, Inc. and Exelixus, Inc. His experience in these organizations has contributed to his expertise in developing innovative solutions in the field of protein kinase modulation.

Collaborations

Throughout his career, Jason has collaborated with notable colleagues such as John M Nuss and Lynne Canne Bannen. These partnerships have further enhanced his research and development efforts.

Conclusion

Jason Jevious Parks is a distinguished inventor whose work in protein kinase modulation has the potential to impact the treatment of various diseases. His innovative patents and collaborations reflect his commitment to advancing biotechnology.

Profile summary based on public USPTO records.